Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 seroprevalence in the municipality of São Paulo, Brazil, ten weeks after the first reported case

Beatriz H. Tess, Celso F. H. Granato, Maria Cecília Goi Porto Alves, Maria Carolina Pintao, Edgar Rizzatti, Marcia C. Nunes, Fernando C. Reinach
doi: https://doi.org/10.1101/2020.06.29.20142331
Beatriz H. Tess
1Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: beatriz.tess@usp.br
Celso F. H. Granato
2Divisão de Pesquisa e Desenvolvimento, Grupo Fleury, São Paulo, Brasil
3Departamento de Medicina, Disciplina de Doenças Infecciosas, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Cecília Goi Porto Alves
4Instituto de Saúde da Secretaria de Saúde do Estado de São Paulo, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Carolina Pintao
2Divisão de Pesquisa e Desenvolvimento, Grupo Fleury, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edgar Rizzatti
2Divisão de Pesquisa e Desenvolvimento, Grupo Fleury, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcia C. Nunes
5Ibope Inteligência, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando C. Reinach
6Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo; no current affiliation, São Paulo, Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

A population-based household survey was performed to estimate the prevalence of IgM and IgG to SARS-CoV-2 in residents of six districts in São Paulo City, Brazil. Serum samples collected from 299 randomly-selected adults and 218 cohabitants (N=517) were tested by chemiluminescence immunoassay ten weeks after the first reported case. Weighted overall seroprevalence was 4.7% (95% CI 3.0-6.6%). The low seroprevalence suggests that most of this population could still be infected. Serial serosurveys were initiated aiming to monitor the progress of the ongoing pandemic throughout the entire city. This may help inform public health authority decisions regarding prevention and control strategies.

Competing Interest Statement

Authors associated with Grupo Fleury (C.F.H.G., M.C.P., E.R.) and Ibope Inteligencia (M.C.N.) disclose the following potential conflict of interest: the two organizations are co-funding the project by providing their services at or below cost. These include data and blood sample collection and laboratory tests. The companies sell these services in the market and might profit from the publicity generated by the results of this research. B.H.T., M.C.G.P.A. and F.C.R. declare no conflict of interest

Funding Statement

The study received funding from Instituto Semeia, Grupo Fleury and Ibope Inteligencia.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Fleury Institutional Ethical Committee (CAAE 31032620.0.0000.5474).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 seroprevalence in the municipality of São Paulo, Brazil, ten weeks after the first reported case
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 seroprevalence in the municipality of São Paulo, Brazil, ten weeks after the first reported case
Beatriz H. Tess, Celso F. H. Granato, Maria Cecília Goi Porto Alves, Maria Carolina Pintao, Edgar Rizzatti, Marcia C. Nunes, Fernando C. Reinach
medRxiv 2020.06.29.20142331; doi: https://doi.org/10.1101/2020.06.29.20142331
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
SARS-CoV-2 seroprevalence in the municipality of São Paulo, Brazil, ten weeks after the first reported case
Beatriz H. Tess, Celso F. H. Granato, Maria Cecília Goi Porto Alves, Maria Carolina Pintao, Edgar Rizzatti, Marcia C. Nunes, Fernando C. Reinach
medRxiv 2020.06.29.20142331; doi: https://doi.org/10.1101/2020.06.29.20142331

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5206)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (747)
  • Geriatric Medicine (76)
  • Health Economics (212)
  • Health Informatics (691)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5798)
  • Intensive Care and Critical Care Medicine (355)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1987)
  • Radiology and Imaging (342)
  • Rehabilitation Medicine and Physical Therapy (155)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)